Pesquisar | مجال

Dbmr Market adicionou um novo artigo أخرى
2025-12-01 11:34:25

Myelodysplastic Syndromes (MDS) Market Size, Share, Trends, Demand, Growth and Competitive Outlook
Myelodysplastic Syndromes (MDS) Market By Type (Myelodysplastic Syndrome with Unilineage Dysplasia, Myelodysplastic Syndrome with Multilineage Dysplasia, Myelodysplastic Syndrome with Ring Sideroblasts, Others), Therapeutic Class (Hypomethylating Agents, Immunomodulatory Drugs, Anti-anemics), Treatment (Supportive Therapy, Growth Factors, Chemotherapy, Stem Cell Transplant, Others), Route...

0 Comentários 0 Compartilhamentos 132 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Dbmr Market adicionou um novo artigo أخرى
2025-12-15 09:08:02

Myelodysplastic Syndromes (MDS) Market Size, Share, Trends, Growth Opportunities, Key Drivers and Competitive Outlook
Myelodysplastic Syndromes (MDS) Market By Type (Myelodysplastic Syndrome with Unilineage Dysplasia, Myelodysplastic Syndrome with Multilineage Dysplasia, Myelodysplastic Syndrome with Ring Sideroblasts, Others), Therapeutic Class (Hypomethylating Agents, Immunomodulatory Drugs, Anti-anemics), Treatment (Supportive Therapy, Growth Factors, Chemotherapy, Stem Cell Transplant, Others), Route...

0 Comentários 0 Compartilhamentos 9 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Dbmr Market adicionou um novo artigo أخرى
2025-12-08 06:35:57

Myelodysplastic Syndromes (MDS) Market Size, Share, Trends, Key Drivers, Growth Opportunities and Competitive Outlook
Myelodysplastic Syndromes (MDS) Market By Type (Myelodysplastic Syndrome with Unilineage Dysplasia, Myelodysplastic Syndrome with Multilineage Dysplasia, Myelodysplastic Syndrome with Ring Sideroblasts, Others), Therapeutic Class (Hypomethylating Agents, Immunomodulatory Drugs, Anti-anemics), Treatment (Supportive Therapy, Growth Factors, Chemotherapy, Stem Cell Transplant, Others), Route...

0 Comentários 0 Compartilhamentos 75 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!